ArticleScientific reports2026
Repetitive transcranial magnetic stimulation is associated with improved functional recovery and time-dependent changes in apoptosis-related execution-phase markers after spinal cord injury.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aimed to determine whether repetitive transcranial magnetic stimulation (rTMS) is associated with changes in motor recovery and apoptosis-related pathways after spinal cord injury (SCI), and to characterize the temporal dependence of these effects. A rat model of SCI was established using Allen's method, and rTMS was initiated on day 2 post-injury. Western blot and immunofluorescence were used to quantify apoptosis-related execution-phase proteins, including caspase-3, cleaved caspase-3, caspase-7, PARP1, and cleaved PARP1, and to assess their cellular distribution. Double immunofluorescence of NeuN and cleaved caspase-3 was performed to identify the localization of apoptotic signals. TUNEL staining, HE staining, and BBB scores were used to assess apoptotic cell death, tissue injury, and motor recovery. rTMS was associated with time-dependent changes, with limited effects at early stages but reduced apoptosis-related signaling and improved tissue preservation and functional recovery at later time points. Co-localization of NeuN and cleaved caspase-3 indicated that apoptotic signaling was localized in neurons. These findings suggest that rTMS is associated with reduced activation of apoptosis-related execution-phase signaling after SCI in a time-dependent manner, together with enhanced tissue preservation and functional recovery. The caspase-3/caspase-7/PARP1 cleavage axis may be involved in the biological changes associated with rTMS treatment after SCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.